건조증 치료 시장 보고서(2025년)
Xerosis Treatment Global Market Report 2025
상품코드 : 1760746
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

건조증 치료제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 5.4%의 연평균 복합 성장률(CAGR)로 116억 9,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 예상되는 성장은 인구 고령화, 환경 오염 증가, 피부 관리 습관 개선에 대한 관심 증가, 피부 관련 건강 문제 증가, 개인용 스킨케어 제품 채택 증가 등의 요인에 기인한 것으로 보입니다. 예측 기간 동안 예상되는 주요 동향으로는 국소 치료의 발전, 보습제 처방 기술 개선, 처방 기반 스킨케어 솔루션의 혁신, 새로운 치료법 임상시험의 발전, 웨어러블 스킨케어 기기 개발 등이 있습니다.

건조증 치료제 시장의 성장 전망은 의료비 지출 증가에 크게 기인합니다. 헬스케어 지출은 개인, 정부, 조직이 예방, 진단, 치료, 질병 관리와 같은 헬스케어 서비스에 할당하는 총 자원을 의미합니다. 의료기술의 발전에 따라 새로운 진단 도구와 치료법은 높은 개발비, 도입비, 지속적인 치료비가 소요되는 경우가 많기 때문에 의료비용은 증가하고 있습니다. 이러한 지출 증가는 피부과 의료에 대한 접근성을 향상시키고, 전문가 지원 및 고급 치료 옵션을 통해 건조증 조기 진단 및 지속적인 관리를 촉진할 수 있습니다. 예를 들어, 2024년 5월 영국 통계청은 2023년 총 의료비 지출이 5.6% 증가하고 2022년 장기 의료 및 사회 보장 지출이 실질 기준으로 2.8% 증가했다고 보고했습니다. 그 결과, 의료비 지출 증가는 건조증 치료 시장의 확장을 주도하고 있습니다.

건조증 치료제 시장의 주요 기업들은 피부 장벽 기능을 개선하고 건성 피부 상태를 더 잘 관리하기 위해 더 오래 지속되는 보습을 제공하는 소프트 로션과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 소프트 로션은 피부에 부드럽게 수분을 공급하도록 설계된 가볍고 끈적임이 없는 보습제로, 민감성 및 일반 피부의 일상적인 사용에 적합합니다. 예를 들어, 2022년 2월 인도 제약회사 카디라 파마슈티컬스(Kadira Pharmaceuticals)는 다양한 건성 피부 질환을 치료할 수 있는 라그로 소프트 로션을 출시했습니다. 이 로션은 건조증, 어루러기, 아토피 피부염, 건조증 등의 질환에 효과적입니다. 또한 피부 노화에도 효과가 있으며, 부신피질 스테로이드와 함께 사용할 수 있습니다. 이 포뮬러는 깊은 보습을 제공하고 피부의 전반적인 건강을 증진시키는 것을 목표로 합니다. 입증된 효능을 가진 라그 글로우 소프트 로션은 피부 관리를 위한 종합적인 솔루션을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Xerosis treatment aims to restore moisture to the skin and repair the skin barrier to alleviate dryness, flaking, and discomfort. This typically involves the use of emollients and moisturizers to hydrate the skin and prevent further water loss. Additionally, gentle skin care practices, such as using mild, fragrance-free cleansers and avoiding hot water or aggressive scrubbing, are essential.

The primary treatments for xerosis include medications and personal care products. Medications are substances or compounds used to diagnose, treat, prevent, or manage medical conditions. These are available in various forms, including tablets, lotions, creams, ointments, and shower products. Medications help address symptoms such as roughness, tightness, itching, and flaky skin, and are used in settings including hospitals, clinics, and home care environments.

The xerosis treatment market research report is one of a series of new reports from The Business Research Company that provides xerosis treatment market statistics, including xerosis treatment global market size, regional shares, competitors with a xerosis treatment market share, xerosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the xerosis treatment. This xerosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The xerosis treatment market size has grown strongly in recent years. It will grow from $8.96 billion in 2024 to $9.47 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth observed during the historical period can be attributed to several factors, including the increasing prevalence of dry skin conditions, growing awareness about skin health, a rise in dermatological consultations, greater availability of over-the-counter moisturizers, and a growing demand for natural and organic skincare products.

The xerosis treatment market size is expected to see strong growth in the next few years. It will grow to $11.69 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth projected during the forecast period can be attributed to factors such as an aging population, rising environmental pollution, an increased focus on improving skincare routines, a rise in skin-related health concerns, and a growing adoption of personalized skincare products. Key trends expected in the forecast period include advancements in topical treatments, improved formulation technologies for moisturizers, innovation in prescription-based skincare solutions, progress in clinical trials for new therapies, and the development of wearable skincare devices.

The projected growth of the xerosis treatment market is largely attributed to the rising healthcare expenditure. Healthcare expenditure refers to the total resources allocated to health services, including prevention, diagnosis, treatment, and disease management, by individuals, governments, and organizations. With advancements in medical technology, healthcare costs are increasing as newer diagnostic tools and treatments often involve higher development, implementation, and ongoing care costs. This increased spending enhances access to dermatological care, facilitating early diagnosis and ongoing management of xerosis through professional support and advanced treatment options. For example, in May 2024, the UK's Office for National Statistics reported that total healthcare spending grew by 5.6% in 2023, while long-term health and social care expenditure rose by 2.8% in real terms in 2022. As a result, the growing healthcare expenditure is driving the expansion of the xerosis treatment market.

Leading companies in the xerosis treatment market are focusing on developing innovative solutions, such as soft lotions, to improve skin barrier function and provide longer-lasting hydration for better management of dry skin conditions. Soft lotion is a lightweight, non-greasy moisturizing formula designed to gently hydrate the skin, making it ideal for daily use on sensitive or normal skin types. For example, in February 2022, Cadila Pharmaceuticals, a pharmaceutical company based in India, introduced Laglo Soft Lotion, formulated to treat a range of dry skin conditions. This lotion is effective in managing disorders such as xerosis, ichthyosis, atopic dermatitis, and psoriasis. It also helps with skin aging and can be used alongside corticosteroids as a co-therapy. The formula aims to offer deep hydration and enhance overall skin health. With its proven effectiveness, Laglo Soft Lotion provides a comprehensive solution for skincare.

In January 2022, Galderma, a Switzerland-based pharmaceutical company, acquired ALASTIN Skincare Inc. for an undisclosed amount. This acquisition was intended to enhance Galderma's dermatology portfolio by incorporating ALASTIN's innovative, physician-recommended skincare products, which complement Galderma's existing offerings. The move also aimed to accelerate ALASTIN's growth by leveraging Galderma's global reach and resources to expand its presence with healthcare professionals and consumers. ALASTIN Skincare Inc. is a US-based company, offering a range of products focused on treating and managing xerosis (dry skin), with an emphasis on hydration, barrier repair, and overall skin health.

Major players in the xerosis treatment market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Unilever PLC, Bayer AG, Sanofi S.A., L'Oreal S.A., GlaxoSmithKline plc, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Galderma S.A., Dr. Reddy's Laboratories Ltd., LEO Pharma A/S, Arcutis Biotherapeutics Inc., Neutrogena, Aveeno, CeraVe, La Roche-Posay, Nivea, and Cetaphil.

North America was the largest region in the xerosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in xerosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the xerosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The xerosis treatment market consists of sales of cleansing bars, body oils and barrier repair creams. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Xerosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on xerosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for xerosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The xerosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Xerosis Treatment Market Characteristics

3. Xerosis Treatment Market Trends And Strategies

4. Xerosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Xerosis Treatment Growth Analysis And Strategic Analysis Framework

6. Xerosis Treatment Market Segmentation

7. Xerosis Treatment Market Regional And Country Analysis

8. Asia-Pacific Xerosis Treatment Market

9. China Xerosis Treatment Market

10. India Xerosis Treatment Market

11. Japan Xerosis Treatment Market

12. Australia Xerosis Treatment Market

13. Indonesia Xerosis Treatment Market

14. South Korea Xerosis Treatment Market

15. Western Europe Xerosis Treatment Market

16. UK Xerosis Treatment Market

17. Germany Xerosis Treatment Market

18. France Xerosis Treatment Market

19. Italy Xerosis Treatment Market

20. Spain Xerosis Treatment Market

21. Eastern Europe Xerosis Treatment Market

22. Russia Xerosis Treatment Market

23. North America Xerosis Treatment Market

24. USA Xerosis Treatment Market

25. Canada Xerosis Treatment Market

26. South America Xerosis Treatment Market

27. Brazil Xerosis Treatment Market

28. Middle East Xerosis Treatment Market

29. Africa Xerosis Treatment Market

30. Xerosis Treatment Market Competitive Landscape And Company Profiles

31. Xerosis Treatment Market Other Major And Innovative Companies

32. Global Xerosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Xerosis Treatment Market

34. Recent Developments In The Xerosis Treatment Market

35. Xerosis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기